13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 69 holding rows worth $304,065,997.
- Accession
- 0001420506-23-002080
- Filer
- CIK 1595851
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 70 entries on the cover page, a total value of $304,065,997 stated on the cover page (in dollars after the unit check, H1), rows summing to $304,065,997 with VALUE read as dollars as filed, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 300,000 | $21,906,000 | dollars as filed | call |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 330,000 | $18,810,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 150,000 | $18,183,000 | dollars as filed | call |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 250,000 | $14,250,000 | dollars as filed | put |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 250,000 | $12,645,000 | dollars as filed | call |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 80,000 | $9,280,000 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 57,500 | $8,397,300 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 1,000,000 | $8,360,000 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 85,000 | $7,959,400 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 110,000 | $7,687,900 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 664,132 | $7,604,311 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 140,000 | $7,137,200 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 400,000 | $7,108,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 185,000 | $7,037,400 | dollars as filed | call |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 400,000 | $6,672,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 650,000 | $6,337,500 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 295,000 | $6,044,550 | dollars as filed | call |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 525,000 | $6,037,500 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 115,000 | $5,816,700 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 130,000 | $4,990,700 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 40,000 | $4,848,800 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 300,000 | $4,356,000 | dollars as filed | put |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 705,881 | $4,334,109 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 250,000 | $4,277,500 | dollars as filed | call |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 275,000 | $4,218,500 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 1,325,000 | $4,187,000 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 325,000 | $4,134,000 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 395,000 | $4,096,150 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 350,000 | $4,014,500 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 215,000 | $3,936,650 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 237,900 | $3,547,089 | dollars as filed | call |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 98,951 | $3,380,166 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 85,000 | $3,263,150 | dollars as filed | put |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 101,443 | $3,016,915 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 200,000 | $2,904,000 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 175,000 | $2,777,250 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 55,000 | $2,773,100 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 201,197 | $2,730,243 | dollars as filed | |
| MORPHOSYS AG | 617760202 | ADR | 400,000 | $2,688,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 90,000 | $2,651,400 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 60,000 | $2,613,600 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 325,000 | $2,596,750 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 225,000 | $2,490,750 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 300,000 | $2,238,000 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 175,000 | $2,128,000 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 12,500 | $2,113,625 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 200,000 | $2,034,000 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 200,000 | $2,034,000 | dollars as filed | put |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 100,000 | $2,006,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 75,000 | $1,977,750 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 80,000 | $1,667,200 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 22,500 | $1,511,325 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 215,000 | $1,442,650 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 75,000 | $1,346,250 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 150,000 | $1,341,000 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 2,500 | $1,229,075 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 35,000 | $1,215,550 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 250,000 | $1,210,000 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 100,000 | $963,000 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 65,000 | $894,400 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 64,000 | $747,520 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 45,000 | $733,500 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 35,000 | $642,250 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 243,287 | $632,546 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 150,000 | $622,500 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 30,000 | $463,200 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 65,000 | $414,700 | dollars as filed | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 325,000 | $280,085 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 61,250 | $77,788 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-002080 | this filing | 2023-11-14 | acceptance time not in the bulk data set |